News and Trends 6 Mar 2025
Top biotech deals of February 2025
Find out about the top biotech partnership deal of February 2025. Small molecules, T-cell engagers, and RNA medicines, were all part of major collaborations.
News and Trends
- Latest Posts
News and Trends 24 Feb 2025
Over $3 billion in a month: Why is Eli Lilly starting 2025 on a buying spree?
This year has seen Eli Lilly sign several licensing deals to bolster its position across a range of therapeutic areas amid growing drug revenues.
News and Trends 19 Feb 2025
Trade war: how new U.S. tariffs will impact the biopharma industry
The U.S. plans to impose trade tariffs on imports. How does this affect the biopharma industry?
News and Trends 13 Feb 2025
DeepMind AlphaFold’s alumnus raises $40m for Latent Labs, a new AI biotech startup
Find out about a new AI-driven company that emerges from stealth today to create novel protein – Latent Labs.
News and Trends 6 Feb 2025
Top biotech deals of January 2025
January 2025 kicked off in full swing with several biotech deals in the biopharma industry.
News and Trends 4 Feb 2025
Akribion Therapeutics emerges from stealth with programmable cell depletion RNA technology
Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach
ADVERTISEMENT
ADVERTISEMENT
News and Trends 31 Jan 2025
U.K. biotech defies the odds, raising £3.5B in 2024
The U.K. biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.
News and Trends 28 Jan 2025
ITM-11 succeeds in phase 3: The first big win for radiopharma?
Discover ITM and its cancer candidate ITM-11, as it brings one of the first big wins the radiopharmaceutical sector awaits.
News and Trends 16 Jan 2025
Top biotech deals of December 2024
The month of December saw a variety of biotech deals take place to advance therapies across different stages in development.
News and Trends 10 Jan 2025
The in vivo revolution: How Interius, Umoja, and Vyriad are transforming CAR-T cell therapy
A U.S. trial of an in vivo CAR gene therapy has expanded to Europe, marking the first-ever trial of its kind in the region.
News and Trends 9 Jan 2025
Von Willebrand disease: Star Therapeutics, Chugai and Band Therapeutics are breaking new ground
Explore advances in von Willebrand disease treatment, including Star Therapeutics’ VGA039, and other key players in the space.
News and Trends 2 Jan 2025
A surge in deals: GSK bets on ADC, neuro and fibrotic diseases to bolster drug development
Last month saw a number of alliances forming in a range of therapeutic spaces but there has been one serial collaborator that stands out – GSK.
ADVERTISEMENT
